Cargando…

Conditional Knockout of N-WASP Enhanced the Formation of Keratinizing Squamous Cell Carcinoma Induced by KRas(G12D)

SIMPLE SUMMARY: The expression of N-WASP (Neural Wiskott-Aldrich Syndrome Protein) is found to be reduced in certain human cancers, and this has been associated with poor prognoses for patients. To characterize the role of N-WASP in the tumorigenesis of squamous cell carcinoma (SCC), we generated mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalailingam, Pazhanichamy, Verma, Apoorva, Lee, Ying Hui, Thanabalu, Thirumaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526518/ https://www.ncbi.nlm.nih.gov/pubmed/37760426 http://dx.doi.org/10.3390/cancers15184455

Ejemplares similares

Conditional knockout of N-WASP in mouse fibroblast caused keratinocyte hyper proliferation and enhanced wound closure
por: Jain, Neeraj, et al.
Publicado: (2016)

Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation
por: Kalailingam, Pazhanichamy, et al.
Publicado: (2017)

Overexpression of GRB2 Enhances Epithelial to Mesenchymal Transition of A549 Cells by Upregulating SNAIL Expression
por: Mitra, Payal, et al.
Publicado: (2018)

N-WASP Attenuates Cell Proliferation and Migration through ERK2-Dependent Enhanced Expression of TXNIP
por: Chung, Yat Joong, et al.
Publicado: (2022)

Overexpression of CDC42SE1 in A431 Cells Reduced Cell Proliferation by Inhibiting the Akt Pathway
por: Kalailingam, Pazhanichamy, et al.
Publicado: (2019)

Molecular difference between WASP and N-WASP critical for chemotaxis of T-cells towards SDF-1α
por: Jain, Neeraj, et al.
Publicado: (2015)

Expression of N-WASP is regulated by HiF1α through the hypoxia response element in the N-WASP promoter
por: Salvi, Amrita, et al.
Publicado: (2016)

X-Linked thrombocytopenia causing mutations in WASP (L46P and A47D) impair T cell chemotaxis
por: Jain, Neeraj, et al.
Publicado: (2014)

Lessons from Keratin 18 Knockout Mice: Formation of Novel Keratin Filaments, Secondary Loss of Keratin 7 and Accumulation of Liver-specific Keratin 8-Positive Aggregates
por: Magin, Thomas M., et al.
Publicado: (1998)

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
por: Misra, Ashish, et al.
Publicado: (2012)

Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions
por: Lubeseder-Martellato, Clara, et al.
Publicado: (2016)

Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
por: Kumar, Gaurav, et al.
Publicado: (2021)

Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods
por: Kulkarni, Apoorva M., et al.
Publicado: (2022)

Deregulated lncRNA expression profile in the mouse lung adenocarcinomas with KRAS‐G12D mutation and P53 knockout
por: Zhang, Meiqin, et al.
Publicado: (2019)

Generation and Characterisation of Keratin 7 (K7) Knockout Mice
por: Sandilands, Aileen, et al.
Publicado: (2013)

KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge
por: Mao, Zhongwei, et al.
Publicado: (2022)

Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS(G12D) or KRAS(G12V) mutations
por: Kun, Eucharist H. S., et al.
Publicado: (2020)

KRAS(G12C)-independent feedback activation of wild-type RAS constrains KRAS(G12C) inhibitor efficacy
por: Ryan, Meagan B., et al.
Publicado: (2022)

Mechanisms of Resistance to KRAS(G12C) Inhibitors
por: Dunnett-Kane, Victoria, et al.
Publicado: (2021)

Evaluation of KRAS(G12C) inhibitor responses in novel murine KRAS(G12C) lung cancer cell line models
por: Sisler, Daniel J., et al.
Publicado: (2023)

TEAD Inhibitors Sensitize KRAS(G12C) Inhibitors via Dual Cell Cycle Arrest in KRAS(G12C)-Mutant NSCLC
por: Tammaccaro, Salvina Laura, et al.
Publicado: (2023)

The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments
Publicado: (1986)

α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice
por: Verma, Raj Kumar, et al.
Publicado: (2016)

Targeting KRAS G12C mutations in colorectal cancer
por: Zhao, Ming-He, et al.
Publicado: (2022)

Bcl-xL Is a Key Mediator of Apoptosis Following KRAS(G12C) Inhibition in KRAS(G12C)-mutant Colorectal Cancer
por: Khawaja, Hajrah, et al.
Publicado: (2023)

Ordering and topological defects in social wasps’ nests
por: Krishna, Shivani, et al.
Publicado: (2022)

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
por: Cucurull, Marc, et al.
Publicado: (2022)

Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice
por: Xu, Mu, et al.
Publicado: (2018)

SCAR knockouts in Dictyostelium: WASP assumes SCAR’s position and upstream regulators in pseudopods
por: Veltman, Douwe M., et al.
Publicado: (2012)

Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
por: Chen, Chih-Chieh, et al.
Publicado: (2013)

Chronic Cystitis Associated With Keratinizing Squamous Metaplasia Progressing to Squamous Papilloma()
por: Puzio, Corinne, et al.
Publicado: (2014)

Overcoming Resistance to Drugs Targeting KRAS(G12C) Mutation
por: Jiao, Delong, et al.
Publicado: (2020)

Searching for treatments for non-G12C-KRAS mutant cancers
por: Guo, Christina, et al.
Publicado: (2021)

KRAS G12C Mutations in NSCLC: From Target to Resistance
por: Addeo, Alfredo, et al.
Publicado: (2021)

The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2021)

Adagrasib: A landmark in the KRAS(G12C)‐mutated NSCLC
por: Tian, He, et al.
Publicado: (2022)

Squamous Metaplasia and Keratinization in Cystic Hyperplasia of the Human Breast
por: Rangam, C. Mohan
Publicado: (1950)

Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
por: Khan, Husain Yar, et al.
Publicado: (2022)

Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS(G12D) inhibitor efficacy in KRAS(G12D)-mutated colorectal cancer
por: Feng, Juanjuan, et al.
Publicado: (2023)

KRAS K104 modification affects the KRAS(G12D)-GEF interaction and mediates cell growth and motility
por: Chen, Chih-Chieh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_apis0gpbv58l16p81jr16jp5lc